Chorioamnionitis future or investigational therapies: Difference between revisions
(Created page with "__NOTOC__ {{Chorioamnionitis}} Please help WikiDoc by adding content here. It's easy! Click here to learn about editing. ==References== {{refli...") |
Adnan Ezici (talk | contribs) No edit summary |
||
(One intermediate revision by one other user not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Chorioamnionitis}} | {{Chorioamnionitis}} | ||
{{CMG}} ; {{AE}} {{Adnan Ezici}} | |||
==Overview== | |||
Future or investigational therapies for clinical chorioamnionitis include administration of vaginal [[antiseptic]] solutions and antenatal [[N-acetylcysteine]] (NAC). | |||
==Future or Investigational Therapies== | |||
Future or investigational therapies for clinical chorioamnionitis include:<ref name="pmid33007269">{{cite journal |vauthors=Conde-Agudelo A, Romero R, Jung EJ, Garcia Sánchez ÁJ |title=Management of clinical chorioamnionitis: an evidence-based approach |journal=Am J Obstet Gynecol |volume=223 |issue=6 |pages=848–869 |date=December 2020 |pmid=33007269 |doi=10.1016/j.ajog.2020.09.044 |url=}}</ref> | |||
*Use of [[antiseptic]] solutions for vaginal cleansing before the procedure of [[cesarean section]] | |||
**It might decrease the risk of poor infectious outcomes caused by clinical chorioamnionitis during the postoperative period. | |||
*Administration of [[N‑acetylcysteine]] (NAC) in patients with clinical chorioamnionitis during the antenatal period | |||
**It might decrease the [[morbidity]] and [[mortality]] in neonates exposed to clinical chorioamnionitis. | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category: | [[Category:NeedsEnglishReview]] | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Obstetrics]] | [[Category:Obstetrics]] | ||
[[Category:Inflammations]] | [[Category:Inflammations]] | ||
[[Category:Bacterial diseases]] | [[Category:Bacterial diseases]] |
Latest revision as of 08:38, 13 June 2021
Chorioamnionitis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Chorioamnionitis future or investigational therapies On the Web |
American Roentgen Ray Society Images of Chorioamnionitis future or investigational therapies |
Chorioamnionitis future or investigational therapies in the news |
Blogs on Chorioamnionitis future or investigational therapies |
Risk calculators and risk factors for Chorioamnionitis future or investigational therapies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Adnan Ezici, M.D[2]
Overview
Future or investigational therapies for clinical chorioamnionitis include administration of vaginal antiseptic solutions and antenatal N-acetylcysteine (NAC).
Future or Investigational Therapies
Future or investigational therapies for clinical chorioamnionitis include:[1]
- Use of antiseptic solutions for vaginal cleansing before the procedure of cesarean section
- It might decrease the risk of poor infectious outcomes caused by clinical chorioamnionitis during the postoperative period.
- Administration of N‑acetylcysteine (NAC) in patients with clinical chorioamnionitis during the antenatal period